$THMO
Market Cap:
$THMO SEC Filings
| Filing | Filed On |
|---|---|
| FORM 4 | 20 Feb 2015 |
| SECOND QUARTER FISCAL YEAR 2015 FINANCIAL RESULTS CONFERENCE CALL | 17 Feb 2015 |
| CESCA THERAPEUTICS INC NT-10Q 12-31-2014 | 17 Feb 2015 |
| CESCA THERAPEUTICS INC 8-K 2-12-2015 | 12 Feb 2015 |
| SABBY 13G-A KOOL 01.09.15 | 09 Jan 2015 |
| FORM 4 | 05 Jan 2015 |
| INDEPENDENT DIRECTOR CURE PERIOD REGAIN COMPLIANCE | 11 Dec 2014 |
| FORM 3 | 10 Dec 2014 |
| FORM 4 | 09 Dec 2014 |
| DAN BESSEY SUPPLEMENT AGREEMENT TO THE EXECUTIVE EMPLOYMENT AGREEMENT | 05 Dec 2014 |
| RHEIN APPOINTMENT TO BOD | 05 Dec 2014 |
| FORM 4/A | 05 Dec 2014 |
| FORM 4 | 03 Dec 2014 |
| KENNETH L. HARRIS, AMENDMENT NO. 2 | 01 Dec 2014 |
| CESCA 8-K INDEPENDENT DIRECTOR CURE PERIOD | 21 Nov 2014 |
| AMENDMENT NO. 2 | 17 Nov 2014 |
| CESCA THERAPEUTICS INC 10-Q 9-30-2014 | 14 Nov 2014 |
| CESCA THERAPEUTICS REPORTS FIRST QUARTER FISCAL 2015 RESULTS | 13 Nov 2014 |
| CESCA THERAPEUTICS INC. CEO | 03 Nov 2014 |
| RESTATED BYLAWS OF CESCA THERAPEUTICS INC. | 30 Oct 2014 |
